HYPERA S.A.

A Publicly-Held Corporation

Corporate Taxpayer ID (CNPJ) No. 02,932,074/0001-91

Company Registry (NIRE) 35,300,353,251

CVM Code No. 21431

NOTICE TO THE MARKET

HYPERA S.A. ("Company" or "Hypera Pharma") hereby informs that, pursuant to the provisions of article 12 of CVM Resolution No., 358, as of August 23rd, 2021, has received, on this date, a notice from Capital International Investors, an independent division of the Capital Research and Management Company ("Capital"), regarding the reduction of equity interest in the Company. Capital informed that manages 60,595,240 common shares of the Company, corresponding to approximately 9.5663% of its capital stock.

The equity movement does not change the corporate position of the Company' significant shareholders and/or its management structure.

Enclosed herewith is the letter sent by Capital.

São Paulo, May 8th, 2024

HYPERA S.A.

Adalmario Ghovatto Satheler do Couto

Investor Relations Officer

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Hypera SA published this content on 08 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 May 2024 03:32:02 UTC.